Notice: This company has been marked as potentially delisted and may not be actively trading.

Elicio Therapeutics (ELTX) Stock Forecast & Price Target

Get the Latest News and Ratings for ELTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Elicio Therapeutics and its competitors.

ELTX Analyst Ratings Over Time

Type	Current Forecast 10/25/23 to 10/24/24	1 Month Ago 9/25/23 to 9/24/24	3 Months Ago 7/27/23 to 7/26/24	1 Year Ago 10/25/22 to 10/25/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	N/A
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$10.00	$10.00	$10.00	N/A
Forecasted Upside	117.39% Upside	100.80% Upside	106.19% Upside	N/A
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	N/A

Billionaires Spot Once-In-25-Year Wealth Opportunity (Ad)

Why November 7th Will Impact Stocks More Than The Election Just 48 hours after the 2024 Presidential Election… A man from a completely different government branch is going to stand up, say a few words… and make history in the stock market.

Click here for the full story.

ELTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ELTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Elicio Therapeutics Stock vs. The Competition

Type	Elicio Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	117.39% Upside	9,785.20% Upside	8.47% Upside
News Sentiment Rating	Neutral News See Recent ELTX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
8/23/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00	+119.78%
4/1/2024	Oppenheimer 3 of 5 stars		Reiterated Rating	Market Perform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:14 AM ET.

ELTX Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Elicio Therapeutics is $10.00, with a high forecast of $10.00 and a low forecast of $10.00.
: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elicio Therapeutics in the last twelve months. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ELTX shares.
: According to analysts, Elicio Therapeutics's stock has a predicted upside of 117.39% based on their 12-month stock forecasts.
: Elicio Therapeutics has been rated by research analysts at HC Wainwright in the past 90 days.
: Analysts like Elicio Therapeutics less than other "medical" companies. The consensus rating score for Elicio Therapeutics is 2.50 while the average consensus rating score for "medical" companies is 2.79. Learn more on how ELTX compares to other companies.